Prosecution Insights
Prosecution Insights
Technology areas: Chemistry & Materials • Transportation, E-Commerce & Mechanical Systems
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Youngblood Ip Holdings LLC is currently handling 2 pending office actions in the Chemistry & Materials technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units. This distribution implies that each active matter is being prosecuted in a different technical and administrative environment. The 2 pending office actions are the only current matters reported for this portfolio within the USPTO's examination structure.
The busiest examiner, DUBOIS, PHILIP A, is responsible for 1 pending office action. With 2 distinct examiners and 2 distinct art units for the 2 pending office actions, the company's prosecution is spread across different USPTO groups. This variety requires managing different examiner styles and art unit standards. Practitioners should note that the filings do not share a common examiner or art unit, which may result in different prosecution timelines for the 2 distinct examiners involved.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| §102 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SANTOS, ROBERT G | 1 | 73.0% | +35.0% |
| DUBOIS, PHILIP A | 1 | 25.5% | +26.3% |
| BALAJ, ANTHONY MICHAEL | 1 | 30.6% | +30.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18405747 | ARTIFICIAL INTELLIGENCE-SUPPORTED CUSTOMIZABLE ACCELERATED AGING FOR DISTILLED SPIRITS | DUBOIS, PHILIP A | 1d overdue |
| 18371236 | HEALTH DATA EXCHANGE PLATFORM | BALAJ, ANTHONY MICHAEL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18405747 | ARTIFICIAL INTELLIGENCE-SUPPORTED CUSTOMIZABLE ACCELERATED AGING FOR DISTILLED SPIRITS | DUBOIS, PHILIP A | 1d overdue |
| 19332679 | BEDDING COMPONENTS INCLUDING FLUID ABSORBING GEL BEADS | SANTOS, ROBERT G | — |
| 18371236 | HEALTH DATA EXCHANGE PLATFORM | BALAJ, ANTHONY MICHAEL | — |
| Art Unit | Apps |
|---|---|
| 3673 | 1 |
| 1791 | 1 |
| 3682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19332679 | BEDDING COMPONENTS INCLUDING FLUID ABSORBING GEL BEADS | SANTOS, ROBERT G | 3673 | §102Other | Non-Final OA | — | Pending | Sep 18, 2025 |
| 18405747 | ARTIFICIAL INTELLIGENCE-SUPPORTED CUSTOMIZABLE ACCELERATED AGING FOR DISTILLED SPIRITS | DUBOIS, PHILIP A | 1791 | §103 | Final Rejection | 1d overdue | Pending | Jan 05, 2024 |
| 18371236 | HEALTH DATA EXCHANGE PLATFORM | BALAJ, ANTHONY MICHAEL | 3682 | §101§112 | Non-Final OA | — | Pending | Sep 21, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial